We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Hope for Improving Gut Health of HIV Sufferers
News

Hope for Improving Gut Health of HIV Sufferers

Hope for Improving Gut Health of HIV Sufferers
News

Hope for Improving Gut Health of HIV Sufferers

Credit: Pixabay.
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Hope for Improving Gut Health of HIV Sufferers "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A UC Davis study found that the damaged gut lining (known as leaky gut) in monkeys infected with chronic simian immunodeficiency virus (SIV), an HIV-like virus, was rapidly repaired within five hours of receiving Lactobacillus plantarum bacteria.

The study, published today in the PNAS, linked chronically inflamed leaky gut to the loss of PPARα signaling (a nuclear receptor protein responsible for regulating cell metabolism) and subsequent damage to mitochondria - the cell’s power house.


The researchers found that L. plantarum activated PPARα signaling and revived mitochondrial flow, repairing the gut barrier in only five hours of exposure.


The outcome lends hope that leaky gut, a common condition among HIV patients, could be effectively treated in the future.


HIV and the damage to the gut lining


The gut, home to majority of the lymphoid tissue in the body, is an early target of HIV. The virus severely damages the immune and epithelial cells in the gut’s lining. This damage leads to an inflamed and leaky gut with weakened defense system and decreased nutrient absorption.


Anti-retroviral therapy (ART) for HIV has been successful in limiting the damage to the body’s immune system. Yet, it has failed to consistently or completely repair the damage to the gut and its lining.


“We wanted to map the pathways that lead to sustained damage in the gut and to identify ways to intervene and support its repair,” said Katti Crakes, doctoral student in the schools of Medicine and Veterinary Medicine at UC Davis and first author on the study.


The researchers found that HIV attacks the gut’s epithelial cells by targeting and draining the mitochondria.


“To reverse the damage caused by HIV and to increase the efficacy of ART, it is important to restore mitochondrial function and to rapidly repair the gut epithelium and immune defense,” said Satya Dandekar, professor of microbiology and immunology at UC Davis School of Medicine and senior author.


Identifying cell signaling regulators for restoring the gut barrier


The bacteria present in the gut are known to play an important role in supporting and repairing the gut functioning. The study specifically tested the impact of L. plantarum bacteria on gut epithelial barrier of SIV infected rhesus macaques.


“We challenged the capacity of L. plantarum bacteria and their metabolites to restore the gut functions in an extremely inflamed visibly disrupted gut environment,” Dandekar said.


The researchers found that L. plantarum were able to survive and remain metabolically active in inflamed gut. The bacteria repaired the gut barrier by targeting and restoring the mitochondria in the intestinal epithelial cells damaged by SIV as well as HIV. These findings provide translational insights into restoring gut immunity and function, both of which are essential for successful HIV cure efforts.

Reference
PPARα-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host–microbe intersection during SIV infection. Katti R. Crakes, Clarissa Santos Rocha, Irina Grishina, Lauren A. Hirao, Eleonora Napoli,  Christopher A. Gaulke,  View ORCID ProfileAnne Fenton, Sandipan Datta, Juan Arredondo, Maria L. Marco, Sumathi Sankaran-Walters, Gino Cortopassi, Cecilia Giulivi, and  Satya Dandekar. PNAS, November 18, 2019, https://doi.org/10.1073/pnas.1908977116.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement